[1]
Mohamad, N.A., Ramachandran, V., Ismail, P., Mohd Isa, H., Chan, Y.M., Ngah, N.F., Md Bakri, N., Ching, S.M., Hoo, F.K., Wan Sulaiman, W.A., Inche Mat, L.N. and Hazmi Mohamed, M. 2018. Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD). Bosnian Journal of Basic Medical Sciences. 18, 3 (Aug. 2018), 260-267. DOI:https://doi.org/10.17305/bjbms.2018.2493.